Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vsee Health (VSEE) EBIT Margin (2023 - 2025)

Vsee Health's EBIT Margin history spans 3 years, with the latest figure at 78.15% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 15922.0% year-over-year to 78.15%; the TTM value through Dec 2025 reached 21.04%, up 68315.0%, while the annual FY2025 figure was 21.04%, 57534.0% up from the prior year.
  • EBIT Margin reached 78.15% in Q4 2025 per VSEE's latest filing, up from 51.69% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 78.15% in Q4 2025 to a low of 1737.85% in Q3 2024.
  • Average EBIT Margin over 3 years is 185.43%, with a median of 51.69% recorded in 2025.
  • Peak YoY movement for EBIT Margin: tumbled -171320bps in 2024, then surged 168616bps in 2025.
  • A 3-year view of EBIT Margin shows it stood at 7.74% in 2023, then crashed by -948bps to 81.07% in 2024, then skyrocketed by 196bps to 78.15% in 2025.
  • Per Business Quant, the three most recent readings for VSEE's EBIT Margin are 78.15% (Q4 2025), 51.69% (Q3 2025), and 66.51% (Q2 2025).